Total Funding
20
43
Total FundingPost-IPO Equity raised
Growth Score
-38 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
120695
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Bruce Rogers: PresidentPast Role: Morphic Therapeutic, CSO
About the Company
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. The company offers the development of therapies for patients with immunological, fibrotic, neoplastic, and vascular diseases, focusing on creating
small molecule inhibitors of various integrin targets.
